Vivere Oncotherapies is a biotechnology research company co-founded by CEO Dr. Melissa Kotterman, focusing on unlocking the full potential of cancer therapies.
Subscribe to see Vivere Oncotherapies’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Vivere Oncotherapies is a biotech company. Its most recent funding round, Seed, raised $8.9M in July 2025. Xcout tracks 5 named people at Vivere Oncotherapies, including Melissa Kotterman (CEO).
As of 16 November 2026. Source: Xcout Intel.
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Seed | $8.9M | 5 named | |
| Seed | $1.4M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Vivere Oncotherapies's closest competitors — see the full list of competitors and alternatives →
OncoRock Therapeutics Inc. is a corporation located in Little Rock, Arkansas. The company operates in the life sciences sector, focusing on the research and development of oncology therapeutics.
OverT Bio, Inc. is a New York-based biotechnology company that pioneers next-generation cellular therapies and biologics at scale. The company focuses on developing effective and safe cellular treatments for solid tumors.
Founded in 2018 and headquartered in San Diego, IconOVir Bio, Inc. is a preclinical-stage biotechnology company that specializes in creating therapies to target cancer cells using engineered viruses.
Haniva Technology LLC is a biotechnology company that develops patented combination therapies and drug delivery devices to treat various forms of cancer. Its research focuses on using non-thermal plasma alongside hypoxia-activated DNA-damaging agents to selectively target and reduce tumor volume, prevent metastasis, and serve as an adjuvant treatment following tumor resection.
Alnair Therapeutics is a biotechnology research company founded in 2022 and headquartered in Chicago, Illinois, dedicated to building cancer therapies that target previously undruggable targets.
Deka Biosciences, Inc. is an early-stage biotechnology holding company located in Germantown, Maryland, focused on developing and delivering life-changing medicines for cancer patients.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Vivere Oncotherapies? Suggest a correction · Work at Vivere Oncotherapies? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.